Pulmonx Corp (LUNG) Stock Price, Quote & News

Company Profile

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also offers LungTraX Platform, a cloud-based quantitative computed tomography a...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 364 0400

Website: pulmonx.com

Address:

700 Chesapeake Drive, Redwood City, United States

beachsidefreddy Jun. 24 at 5:49 PM

$LUNG LOOK SHORTS RETURNING BIG TIME https://fintel.io/ss/us/lung

0 · Reply

beachsidefreddy Jun. 24 at 5:08 PM

$LUNG AERISEAL NEXT WEEK AFTER RUSSELL REBALANCE OVER !!

0 · Reply

beachsidefreddy Jun. 23 at 12:18 PM

$LUNG NEW HHS RULING ON DRUG FASTRACKING ETC MAY HELP AERISEAL!!!!!!!

1 · Reply

cv3 Jun. 22 at 6:05 PM

$LUNG no messages for pulmonx but 600+ watchers. must have some filter turned on.

0 · Reply

beachsidefreddy Jun. 22 at 3:03 PM

$LUNG 20,000 bid!!!!!!!

0 · Reply

beachsidefreddy Jun. 22 at 1:35 PM

$LUNG shorts have returned highest in 6 months

0 · Reply

beachsidefreddy Jun. 22 at 12:07 PM

$LUNG I SAY AGAIN BLOW OUT MONDAY

1 · Reply

beachsidefreddy Jun. 18 at 7:36 PM

$LUNG we are about to blow could be Monday

0 · Reply

beachsidefreddy Jun. 18 at 2:58 PM

$LUNG I knew when the shorts returned all that stock this was gonna happen

0 · Reply

beachsidefreddy Jun. 18 at 2:17 PM

$LUNG MICHAEL !! LUNG is being deleted from the Russell on the 22nd for capitalization numbers, but most of the funds sell well before that knowing that it’s gonna happen, that’s what I think we’ve been seeing and often times they get oversold and then the stocks from rocket after the actual date of the 22nd

0 · Reply

Pulmonx Transcript: AGM 2026

Jun 1, 2026, 4:05 PM EDT - 23 days ago

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 12, 2026, 11:15 AM EDT - 6 weeks ago

Pulmonx Transcript: Bank of America Global Healthcare Conference 2026

2026-04-29T20:32:57.000Z - 2 months ago

Pulmonx reports Q1 EPS (33c), consensus (33c)

2026-04-29T20:30:26.000Z - 2 months ago

Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.87M

Apr 29, 2026, 4:30 PM EDT - 2 months ago

Pulmonx Earnings Call Transcript: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

Pulmonx Earnings release: Q1 2026

Apr 29, 2026, 4:30 PM EDT - 2 months ago

Pulmonx Quarterly report: Q1 2026

Apr 29, 2026, 4:05 PM EDT - 2 months ago

Pulmonx Reports First Quarter 2026 Financial Results

Apr 28, 2026, 4:05 PM EDT - 2 months ago

Pulmonx to Present at the Bank of America Securities 2026 Health Care Conference

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Pulmonx Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

Pulmonx Proxy statement: Proxy filing

Apr 15, 2026, 4:05 PM EDT - 2 months ago

Pulmonx to Report First Quarter 2026 Financial Results on April 29, 2026

2026-03-05T11:42:24.000Z - 3 months ago

Pulmonx price target lowered to $5 from $6 at Canaccord

2026-03-04T21:39:51.000Z - 4 months ago

Pulmonx reports Q4 EPS (25c), consensus (38c)

2026-03-04T21:38:59.000Z - 4 months ago

Pulmonx sees FY26 revenue $90M-$92M, consensus $94.23M

Mar 4, 2026, 4:30 PM EST - 4 months ago

Pulmonx Earnings Call Transcript: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Pulmonx Annual report: Q4 2025

Mar 4, 2026, 4:30 PM EST - 4 months ago

Pulmonx Earnings release: Q4 2025

Mar 4, 2026, 4:06 PM EST - 4 months ago

Pulmonx Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 4, 2026, 4:05 PM EST - 4 months ago

Pulmonx Announces Closing of up to $60 Million Credit Facility

Mar 4, 2026, 7:00 AM EST - 4 months ago

Pulmonx Slides: Investor presentation

Feb 20, 2026, 8:00 AM EST - 4 months ago

Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026

Dec 3, 2025, 4:05 PM EST - 7 months ago

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Nov 24, 2025, 7:00 AM EST - 7 months ago

Pulmonx Registration statement: Registration Filing

2025-11-12T21:50:46.000Z - 8 months ago

Pulmonx reports Q3 EPS (34c), consensus (42c)

2025-11-12T21:50:40.000Z - 8 months ago

Pulmonx cuts FY25 revenue view to $89M-$90M from $90M-$92M

Nov 12, 2025, 4:30 PM EST - 8 months ago

Pulmonx Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Pulmonx Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 8 months ago

Pulmonx Earnings release: Q3 2025

Nov 12, 2025, 4:05 PM EST - 8 months ago

Pulmonx Reports Third Quarter 2025 Financial Results

2025-10-28T12:45:40.000Z - 8 months ago

Pulmonx price target lowered to $4 from $8 at Lake Street

2025-10-27T20:16:44.000Z - 8 months ago

Pulmonx CEO Steve Williamson resigns, Glen French succeeds

2025-10-27T20:16:21.000Z - 8 months ago

Pulmonx reports preliminary Q3 revenue $21.5M, consensus $20.78M

Oct 27, 2025, 4:05 PM EDT - 8 months ago

Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025

Oct 15, 2025, 4:05 PM EDT - 9 months ago

Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025

2025-09-26T21:25:28.000Z - 9 months ago

Pulmonx files $200M mixed securities shelf

Sep 26, 2025, 8:00 AM EDT - 9 months ago

Pulmonx Registration statement: Registration Filing

Sep 4, 2025, 4:30 PM EDT - 10 months ago

Pulmonx Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 26, 2025, 4:05 PM EDT - 10 months ago

Pulmonx to Participate in September Investor Conferences

Aug 12, 2025, 10:00 AM EDT - 11 months ago

Pulmonx Transcript: Canaccord Genuity’s 45th Annual Growth Conference

2025-07-31T13:07:02.000Z - 11 months ago

Pulmonx price target lowered to $8 from $12 at Lake Street

2025-07-31T09:10:37.000Z - 11 months ago

Pulmonx downgraded to Neutral from Overweight at Piper Sandler

Jul 30, 2025, 4:30 PM EDT - 11 months ago

Pulmonx Earnings Call Transcript: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 11 months ago

Pulmonx Quarterly report: Q2 2025

Jul 30, 2025, 4:30 PM EDT - 11 months ago

Pulmonx Earnings release: Q2 2025

2025-07-30T20:17:04.000Z - 11 months ago

Pulmonx reports Q2 EPS (38c), consensus (40c)

2025-07-30T20:15:53.000Z - 11 months ago

Pulmonx cuts FY25 revenue view to $90M-$92M from $96M-$98M, consensus $96.95M

Jul 30, 2025, 4:05 PM EDT - 11 months ago

Pulmonx Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025

Jun 11, 2025, 10:00 AM EDT - 1 year ago

Pulmonx Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

2025-05-22T10:41:01.000Z - 1 year ago

Pulmonx price target lowered to $4.15 from $6.50 at Citi

May 14, 2025, 12:35 PM EDT - 1 year ago

Pulmonx Transcript: Bank of America 2025 Healthcare Conference

May 1, 2025, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

2025-05-01T11:03:30.000Z - 1 year ago

Pulmonx price target lowered to $9 from $10 at Piper Sandler

2025-05-01T10:56:40.000Z - 1 year ago

Pulmonx price target lowered to $15 from $16 at Canaccord

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Quarterly report: Q1 2025

Apr 30, 2025, 4:30 PM EDT - 1 year ago

Pulmonx Earnings release: Q1 2025

2025-04-30T20:21:35.000Z - 1 year ago

Pulmonx reports Q1 EPS (36c), consensus (40c)

2025-04-30T20:20:42.000Z - 1 year ago

Pulmonx backs FY25 revenue view $96M-$98M, consensus $96.98M

Apr 30, 2025, 4:05 PM EDT - 1 year ago

Pulmonx Reports First Quarter 2025 Financial Results

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Pulmonx Proxy statement: Proxy Filing

Apr 8, 2025, 8:00 AM EDT - 1 year ago

Pulmonx Proxy statement: Proxy Filing

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

Feb 27, 2025, 11:00 AM EST - 1 year ago

Pulmonx Transcript: Citi’s 2025 Medtech and Life Sciences Access Day

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Earnings Call Transcript: Q4 2024

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Annual report: Q4 2024

Feb 19, 2025, 4:30 PM EST - 1 year ago

Pulmonx Earnings release: Q4 2024

Feb 19, 2025, 4:05 PM EST - 1 year ago

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

Feb 19, 2025, 7:00 AM EST - 1 year ago

Pulmonx Slides: Investor Presentation

Feb 13, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

Feb 5, 2025, 4:05 PM EST - 1 year ago

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

Dec 4, 2024, 12:30 PM EST - 1 year ago

Pulmonx Transcript: Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 9:10 AM EST - 1 year ago

Pulmonx Transcript: Stifel 2024 Healthcare Conference

Nov 19, 2024, 9:00 AM EST - 1 year ago

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Nov 5, 2024, 4:05 PM EST - 1 year ago

Pulmonx to Present at the Stifel 2024 Healthcare Conference

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Earnings Call Transcript: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Quarterly report: Q3 2024

Oct 30, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Earnings release: Q3 2024

Oct 16, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

Sep 9, 2024, 4:05 PM EDT - 1 year ago

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

Sep 5, 2024, 4:30 PM EDT - 1 year ago

Pulmonx Transcript: 2024 Wells Fargo Healthcare Conference

Aug 29, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

Aug 22, 2024, 4:05 PM EDT - 1 year ago

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Pulmonx Transcript: Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Quarterly report: Q2 2024

Jul 31, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings release: Q2 2024

Jul 31, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Reports Second Quarter 2024 Financial Results

Jul 29, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

Jul 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q1 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Quarterly report: Q1 2024

May 1, 2024, 4:30 PM EDT - 2 years ago

Pulmonx Earnings release: Q1 2024

May 1, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Reports First Quarter 2024 Financial Results

Apr 10, 2024, 4:05 PM EDT - 2 years ago

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Pulmonx Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Pulmonx Proxy statement: Proxy Filing

Apr 2, 2024, 4:05 PM EDT - 2 years ago

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

Feb 26, 2024, 8:00 AM EST - 2 years ago

Pulmonx Announces Treatment of the First Patient with the AeriSeal® System in CONVERT II Pivotal Trial

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Earnings Call Transcript: Q4 2023

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Annual report: Q4 2023

Feb 21, 2024, 4:30 PM EST - 2 years ago

Pulmonx Earnings release: Q4 2023

Feb 21, 2024, 4:06 PM EST - 2 years ago

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 4:05 PM EST - 2 years ago

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

Feb 7, 2024, 4:05 PM EST - 2 years ago

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

Nov 29, 2023, 2:00 PM EST - 2 years ago

Pulmonx Transcript: Piper Sandler 35th Annual Healthcare Conference

Nov 15, 2023, 4:05 PM EST - 2 years ago

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

Oct 31, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Participate at Upcoming Investor Conferences

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Earnings Call Transcript: Q3 2023

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Quarterly report: Q3 2023

Oct 30, 2023, 4:30 PM EDT - 2 years ago

Pulmonx Earnings release: Q3 2023

Oct 30, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Reports Record Third Quarter 2023 Financial Results

Oct 30, 2023, 3:30 PM EDT - 2 years ago

Pulmonx Slides: Investor Presentation

Oct 16, 2023, 4:05 PM EDT - 2 years ago

Pulmonx to Report Third Quarter 2023 Financial Results on October 30, 2023

Oct 10, 2023, 4:05 PM EDT - 2 years ago

Pulmonx Announces CFO Transition and Record Preliminary Third Quarter 2023 Revenue

Sep 6, 2023, 2:15 PM EDT - 3 years ago

Pulmonx Transcript: Wells Fargo Securities Healthcare Conference 2023

Aug 2, 2023, 8:00 PM EDT - 3 years ago

Pulmonx Slides: Investor Presentation

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings Call Transcript: Q2 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Quarterly report: Q2 2023

Aug 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings release: Q2 2023

Aug 2, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Reports Second Quarter 2023 Financial Results

Jul 26, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Present at the Canaccord Genuity 43rd Annual Growth Conference

Jul 17, 2023, 8:00 AM EDT - 3 years ago

Pulmonx to Report Second Quarter 2023 Financial Results on August 2, 2023

May 9, 2023, 6:55 PM EDT - 3 years ago

Pulmonx Transcript: Bank of America Global Healthcare Conference 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings Call Transcript: Q1 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Quarterly report: Q1 2023

May 2, 2023, 4:30 PM EDT - 3 years ago

Pulmonx Earnings release: Q1 2023

May 2, 2023, 4:05 PM EDT - 3 years ago

Pulmonx Reports First Quarter 2023 Financial Results

May 1, 2023, 5:00 AM EDT - 3 years ago

Pulmonx Slides: Investor Presentation

Apr 25, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Present at the Bank of America Securities 2023 Health Care Conference

Apr 18, 2023, 4:05 PM EDT - 3 years ago

Pulmonx to Report First Quarter 2023 Financial Results on May 2, 2023

Apr 4, 2023, 8:00 AM EDT - 3 years ago

Pulmonx Proxy statement: Proxy Filing

Apr 4, 2023, 8:00 AM EDT - 3 years ago

Pulmonx Proxy statement: Proxy Filing

Mar 2, 2023, 3:30 PM EST - 3 years ago

Pulmonx Transcript: Citi Healthcare & Medtech Conference

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Earnings Call Transcript: Q4 2022

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Annual report: Q4 2022

Feb 22, 2023, 4:30 PM EST - 3 years ago

Pulmonx Earnings release: Q4 2022

Feb 22, 2023, 4:05 PM EST - 3 years ago

Pulmonx Reports Fourth Quarter and Full Year 2022 Financial Results

beachsidefreddy Jun. 24 at 5:49 PM

$LUNG LOOK SHORTS RETURNING BIG TIME https://fintel.io/ss/us/lung

0 · Reply

beachsidefreddy Jun. 24 at 5:08 PM

$LUNG AERISEAL NEXT WEEK AFTER RUSSELL REBALANCE OVER !!

0 · Reply

beachsidefreddy Jun. 23 at 12:18 PM

$LUNG NEW HHS RULING ON DRUG FASTRACKING ETC MAY HELP AERISEAL!!!!!!!

1 · Reply

cv3 Jun. 22 at 6:05 PM

$LUNG no messages for pulmonx but 600+ watchers. must have some filter turned on.

0 · Reply

beachsidefreddy Jun. 22 at 3:03 PM

$LUNG 20,000 bid!!!!!!!

0 · Reply

beachsidefreddy Jun. 22 at 1:35 PM

$LUNG shorts have returned highest in 6 months

0 · Reply

beachsidefreddy Jun. 22 at 12:07 PM

$LUNG I SAY AGAIN BLOW OUT MONDAY

1 · Reply

beachsidefreddy Jun. 18 at 7:36 PM

$LUNG we are about to blow could be Monday

0 · Reply

beachsidefreddy Jun. 18 at 2:58 PM

$LUNG I knew when the shorts returned all that stock this was gonna happen

0 · Reply

beachsidefreddy Jun. 18 at 2:17 PM

0 · Reply

beachsidefreddy Jun. 18 at 1:03 PM

$LUNG SHORTS JUST RETURNED HUGE AMOUNT!!!!!!!!

0 · Reply

beachsidefreddy Jun. 17 at 5:20 PM

$LUNG with FDA approval of QURE THERE’S A CHANCE FDA MAY FAST TRACK AERISEAL!!

1 · Reply

beachsidefreddy Jun. 17 at 2:28 PM

$LUNG PUT OUT AERISEAL NEWS TODAY XBI UP $4!!!

0 · Reply

beachsidefreddy Jun. 17 at 1:42 PM

$LUNG 40,000 in in 12 minutes unheard of

0 · Reply

beachsidefreddy Jun. 16 at 4:48 PM

$LUNG BLOCKS!!!!!!!!!!!! something about to happen

0 · Reply

beachsidefreddy Jun. 16 at 1:00 PM

$LUNG today opposite of yesterday I think AERISEAL news coming big move higher

0 · Reply

beachsidefreddy Jun. 15 at 9:48 PM

$LUNG could this all be RSU related selling for taxes? If so will rocket soon and we have AERISEAL NEWS AHEAD

0 · Reply

beachsidefreddy Jun. 15 at 7:14 PM

$LUNG just halt and do deal at $14 like Kolbert picked!!

0 · Reply

beachsidefreddy Jun. 15 at 6:06 PM

$LUNG WTF is going on

1 · Reply

beachsidefreddy Jun. 15 at 3:13 PM

$LUNG GSCO SHOULD NOT BE ON BOX IN $1.30 BUT THEY ARE…. BE READY

0 · Reply

beachsidefreddy Jun. 15 at 2:21 PM

$LUNG this is complete bullshit. These guys are buyers not sellers every big trade of three or 4000 shares is on and uptick.

0 · Reply

beachsidefreddy Jun. 15 at 2:09 PM

$LUNG unless French wants to go to SEC jail there better be some news about air seal coming very shortly a publication since he said that it minute at 9:05 in the Bank of America bio conference that was a while ago and he said it was coming soon

0 · Reply

Market Cap	54.06M
Revenue (ttm)	90.50M
Net Income (ttm)	-54.00M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-59.67%
Debt to Equity Ratio	0.81

Volume	571,700
Avg Vol	442,888
Day's Range	N/A - N/A
Shares Out	42.24M
Stochastic %K	17%
Beta	0.28
Analysts	Sell
Price Target	$3.40